Your browser doesn't support javascript.
loading
Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial.
Taucher, Christian; Lazarus, Rajeka; Dellago, Hanna; Maurer, Gabriele; Weisova, Petronela; Corbic-Ramljak, Irena; Dubischar, Katrin; Lilja, Anders; Eder-Lingelbach, Susanne; Hochreiter, Romana; Jaramillo, Juan Carlos; Junker, Helga; Krammer, Michael; Pusic, Petra; Querton, Benedicte; Larcher-Senn, Julian; Hoffmann, Markus; Pöhlmann, Stefan; Finn, Adam.
Afiliación
  • Taucher C; Valneva Austria GmbH, Vienna, Austria. Electronic address: christian.taucher@valneva.com.
  • Lazarus R; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
  • Dellago H; Valneva Austria GmbH, Vienna, Austria.
  • Maurer G; Valneva Austria GmbH, Vienna, Austria.
  • Weisova P; Valneva Austria GmbH, Vienna, Austria.
  • Corbic-Ramljak I; Valneva Austria GmbH, Vienna, Austria.
  • Dubischar K; Valneva Austria GmbH, Vienna, Austria.
  • Lilja A; Valneva Austria GmbH, Vienna, Austria.
  • Eder-Lingelbach S; Valneva Austria GmbH, Vienna, Austria.
  • Hochreiter R; Valneva Austria GmbH, Vienna, Austria.
  • Jaramillo JC; Valneva Austria GmbH, Vienna, Austria.
  • Junker H; Valneva Austria GmbH, Vienna, Austria.
  • Krammer M; Valneva Austria GmbH, Vienna, Austria.
  • Pusic P; Valneva Austria GmbH, Vienna, Austria.
  • Querton B; Valneva Austria GmbH, Vienna, Austria.
  • Larcher-Senn J; Assign Data Management and Biostatistics GmbH, Stadlweg 23, 6020 Innsbruck, Austria.
  • Hoffmann M; Infection Biology Unit, German Primate Center, Kellnerweg 4, 37077 Göttingen, Germany; Faculty of Biology and Psychology, Georg-August-University Göttingen, 37073 Göttingen, Germany.
  • Pöhlmann S; Infection Biology Unit, German Primate Center, Kellnerweg 4, 37077 Göttingen, Germany; Faculty of Biology and Psychology, Georg-August-University Göttingen, 37073 Göttingen, Germany.
  • Finn A; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK; Bristol Vaccine Centre, Schools of Population Health Sciences and Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
J Infect ; 87(3): 242-254, 2023 09.
Article en En | MEDLINE | ID: mdl-37406777
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: J Infect Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: J Infect Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido